4.8 Editorial Material

Does the World Still Need New Covid-19 Vaccines?

Journal

NEW ENGLAND JOURNAL OF MEDICINE
Volume 386, Issue 22, Pages 2140-2142

Publisher

MASSACHUSETTS MEDICAL SOC
DOI: 10.1056/NEJMe2204695

Keywords

-

Ask authors/readers for more resources

Although there was a global shortage of Covid-19 vaccines in 2021, by mid 2022, vaccine supply will no longer be a limiting factor in achieving more equitable coverage. Efforts to scale up manufacturing capacity through the COVAX program and other means are projected to meet the World Health Organization's target of vaccinating 70% of the global population by mid 2022.
Although there was a global shortage of Covid-19 vaccines in 2021, by mid 2022, the vaccine supply will no longer be a limiting factor in efforts to provide more equitable coverage. As of April 19, 2022, approximately 11.5 billion Covid-19 vaccine doses have been administered globally.(1) Scaling up manufacturing capacity for currently available vaccines at the speed promised by vaccine producers through the COVAX (Covid-19 Vaccines Global Access) program and beyond should secure the coverage target projected by the World Health Organization (WHO) for 70% of the world population by mid 2022.(2) So why do we still need new Covid-19 . . .

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available